Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: Part II

Journal of Psychiatric Practice
Sheldon H PreskornDavid Flockhart


No abstract listed.


Oct 6, 2000·Life Sciences·R S El-BacháA Minn
Oct 2, 2001·BJU International·A Argiolas, H Hedlund
Mar 7, 2003·Clinical Pharmacology and Therapeutics·Michael H SkinnerStephen D Wise
Jun 26, 2003·International Journal of Impotence Research·F Montorsi
Dec 4, 2003·CNS Drug Reviews·Shiho HirotaShigeru Okuyama
Dec 9, 2003·European Journal of Pharmacology·Raymond S HurstMartin D Meglasson
Mar 24, 2004·Neurology·Mark Stacy
Dec 8, 2004·Journal of Psychiatric Practice·Sheldon H Preskorn
Dec 14, 2004·Journal of Neurology·Hilary L TyneMalcolm J Steiger
Apr 12, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Katherine L Widnell, Cynthia Comella
Jun 1, 2005·European Journal of Pharmacology·Hideji MorishitaTakeshi Katsuragi
Feb 10, 2006·Expert Review of Neurotherapeutics·Ubaldo Bonuccelli, Nicola Pavese
Aug 3, 2006·Journal of Psychiatric Practice·Alfredo Bellon
Aug 3, 2006·Journal of Psychiatric Practice·Sheldon H PreskornDavid Flockhart

❮ Previous
Next ❯


Aug 14, 2009·Journal of Affective Disorders·Raymond W LamUNKNOWN Canadian Network for Mood and Anxiety Treatments (CANMAT)
Apr 23, 2013·Acta Psychiatrica Scandinavica. Supplementum·G S MalhiK Fritz
Oct 25, 2007·Expert Opinion on Pharmacotherapy·Ihtsham Ul HaqHubert H Fernandez
Feb 2, 2015·Critical Reviews in Oncology/hematology·Florence RanchonBenoit You
Apr 7, 2007·Journal of Psychiatric Practice·Sheldon H Preskorn, Ronald L Lacey
Dec 18, 2008·Expert Review of Neurotherapeutics·Jayesh Kamath, Venkatesh Handratta

❮ Previous
Next ❯

Related Concepts

Related Feeds


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.